Living Our Values
Our Environmental, Social, and Governance commitments help us to deliver on our purpose every day. Learn more about our progress on our goals in our ESG report.
2022 ESG Highlights
Environment
The health of our global environment impacts everyone. At Pfizer, we are committed to reducing our environmental footprint. Our company purpose—Breakthroughs that change patients’ lives—guides our environmental priorities, with a focus on impact reduction, conservation of resources, and the minimization of waste arising from our operations.
Net-Zero Standard
Aiming to achieve by 2040, which is 10 years earlier than expectations of the standard
Leadership Level
for our CDP Climate Change Disclosure
11%
Reduction in Scope 1 & 2 greenhouse gas (GHG) emissions from 2019 baseline
Social
At Pfizer, our purpose—Breakthroughs that change patients’ lives—is rooted in achieving social good. We know that when we succeed, our breakthroughs can potentially have life-changing effects. We aim to be the solution for illnesses from widespread infectious diseases to conditions with historically unmet need.
Pfizer is mindful of the urgency of our mission, as the world fights against the spread of deadly new diseases and struggles with inequities in health outcomes among populations. Our goal is to leverage partnerships and programs to allow quick and widespread access to our breakthrough medicines and vaccines across all corners of the world.
#1
Ranking among the largest Pharma companies in the most recent Global PatientView Survey (#2 overall)
43.1%
Representation for women at VP+ levels globally. 28.1% Representation for U.S. minorities at VP+ level
44%
Pfizer New Molecular Entity and novel biologic applications approved by the FDA between 2018-2022 designated as Breakthrough Therapies
Governance
Ethical decision-making guides us as we work to achieve our purpose of delivering Breakthroughs that change patients’ lives. Through proactive, business-led risk management, Pfizer prioritizes integrity, safety, and quality in every aspect of our business. Our Board of Directors is actively engaged in the governance and oversight of our ESG strategy, which is embedded within our enterprise strategy.
4 out of 12
Members of the board of directors are women3 out of 12 members of the Board of Directors are ethnically diverse
30k
Pfizer leaders have ESG KPIs factored into their compensation
